Indefinite Delivery Contract 75D30126D21000
Award Date 6/1/26
Last Date to Order 5/31/27
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Centers for Disease Control and Prevention, on behalf of its Office of Acquisition Services, awarded an indefinite-delivery, multiple-award contract to Moderna US, Inc. with a ceiling value of $29,183,000 and an award date of June 1, 2026. The contract runs through May 31, 2027. The solicitation, posted March 4, 2026 with proposals due March 17, 2026, sought FDA-approved COVID-19 vaccines for adults aged 19 and older to support the Section 317 immunization program, which distributes vaccines...
- This Indefinite Delivery Contract awards Moderna US, Inc. authority to supply pediatric COVID-19 vaccines to the Centers for Disease Control and Prevention (CDC) under a multiple award arrangement with a ceiling value of $196.9 million. The contract, awarded June 1, 2025, establishes an indefinite quantity vehicle with an ultimate completion date of May 31, 2026, representing a one-year performance period. As a civilian procurement through the CDC Pittsburgh division, this IDV supports the...
- This multiple award indefinite delivery contract, awarded June 1, 2024, provides the Centers for Disease Control and Prevention (CDC) with pediatric COVID-19 messenger RNA vaccines manufactured by Moderna US, Inc. The contract carries a ceiling value of $481.1 million with an ultimate completion date of September 30, 2025, and represents a one-year performance period. The CDC, a civilian federal agency, issued this procurement without set-aside restrictions to ensure continued availability of...
- This multiple award indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) on June 1, 2024, establishes a supply vehicle for COVID-19 adult vaccines with a ceiling value of $117.4 million and an ultimate completion date of September 30, 2025. Moderna US, Inc. serves as the prime contractor under this civilian, non-set-aside procurement. The contract enables the federal government to acquire messenger RNA (mRNA) vaccines for adult populations as part of...
- The Centers for Disease Control and Prevention (CDC) awarded a multiple-award indefinite-delivery contract to Pfizer Inc. on June 1, 2026, with a ceiling of $735,720,598 for pediatric COVID-19 vaccines under the Vaccine for Children (VFC) program. The contract has no set-aside designation and a completion date of May 31, 2027. Place of performance centers in Chamblee, Georgia, with vaccine delivery to CDC centralized distribution locations in Olive Branch, Mississippi and Clermont, Kentucky...
- Moderna US, Inc. was awarded a multiple award indefinite delivery contract by the Centers for Disease Control and Prevention (CDC) with a contract ceiling of $1.62 million and a period of performance extending through June 30, 2026. The contract was awarded on July 1, 2025, under the VACCINES major program code with no set-aside designation. Under this indefinite delivery vehicle, Moderna will supply adult COVID-19 messenger RNA (mRNA) vaccines to support the CDC's immunization and pandemic...
- Moderna US, Inc. was awarded a multiple award Indefinite Delivery Contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh, a civilian federal agency, to supply adult COVID-19 messenger RNA vaccines. The contract, valued at $39.71 million with no set-aside provision, was awarded on June 1, 2025, and extends through May 31, 2026. The procurement falls under the VACCINES major program code and represents the federal government's continued efforts to maintain vaccine supply and...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Sanofi Vaccines US Inc. on June 1, 2026, with a ceiling of $15,682,800 to procure FDA-approved COVID-19 vaccines for adults aged 19 and older through May 31, 2027. The solicitation, posted March 4, 2026 with proposals due March 17, 2026, sought vaccines to support the Section 317 immunization program, which distributes vaccines to state and local health departments across all fifty states,...
- The Centers for Disease Control and Prevention awarded a multiple-award indefinite-delivery contract to Pfizer Inc. on June 1, 2026, with a ceiling value of $505,272,000 for FDA-approved COVID-19 vaccines for adults aged 19 and older under Executive Order 14398. No set-aside applies. The contract supports the CDC's Section 317 immunization program, which distributes vaccines to state and local health departments across all fifty states, several large city programs, and U.S. Territories. Place of...
- The Centers for Disease Control and Prevention (CDC) has awarded a multiple award indefinite delivery indefinite quantity (IDIQ) contract for the purchase of standard commercial COVID-19 vaccines with a pediatric indication. The maximum ordering quantity is 30 million doses, with a minimum order of 100 doses. The vaccines procured will support pediatric immunization programs through the Vaccines for Children (VFC) and Section 317 vaccine purchase programs. The IDIQ has a ceiling value of...